MS
NEUE

Marshall & Sullivan’s NeueHealth NEUE Stock Holding History

Marshall & Sullivan’s Portfolio NEUE Stock Details NEUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-375
Closed -$2.59K – 116
2025
Q2 		$2.59K Buy
+375
New +$2.52K ﹤0.01% 112
2023
Q2 		– Sell
-375
Closed -$6.61K – 39
2023
Q1 		$6.61K Hold
375
– – ﹤0.01% 39
2022
Q4 		$19.5K Hold
375
– – 0.01% 75
2022
Q3 		$31K Buy
+375
New +$49.8K 0.02% 37

Other funds holding NEUE

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RM
Redpoint Management Woodside, California $204M AUM 31.92% 1-Year Est. Return
G
Greycroft New York $44.1M AUM 24.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Marshall & Sullivan's NEUE Position: Q3 2025 in Review

Marshall & Sullivan sold out of NeueHealth (NEUE) in Q3 2025, closing a stake of 375 shares — an estimated $2.59K sold.

Marshall & Sullivan first reported a position in NEUE in Q3 2022 and held it in 4 quarters. The position peaked at $31K in Q3 2022. 38 funds tracked by Wall St. Rank hold NEUE as of Q3 2025.

  • Marshall & Sullivan reported no remaining NeueHealth position as of Q3 2025 after selling out during the quarter.
  • Marshall & Sullivan sold 375 NeueHealth shares in Q3 2025, an estimated $2.59K.
  • Marshall & Sullivan first reported a position in NeueHealth in Q3 2022 and held it in 4 quarters.
  • Marshall & Sullivan's NeueHealth position peaked at $31K in Q3 2022.
  • 38 funds tracked by Wall St. Rank held NeueHealth as of Q3 2025.

Based on Marshall & Sullivan's 13F filing for Q3 2025, filed 15 Oct 2025.